Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of both genders with striae distensae of all grades present over any part of the body. 2. Patients who have not taken treatment for striae distensae either topical or systemic in the past 6 months
Exclusion criteria
Exclusion criteria: 1. Patients on topical retinoids or systemic corticosteroids. 2. Patients with history of keloid formation. 3. Patients with any connective tissue disease. 4. Patients with disease affecting the wound-healing process. 5. Patients with other systemic illness bleeding disorders , cardiac, renal, hepatic illness. 6. Pregnancy, Lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess and compare the efficacy of Fractional CO2 Laser and Poly-l-lactic acid (PLLA) Gel versus Fractional CO2 Laser in the treatment of Striae DistensaeTimepoint: at an interval of 4 weeks for a total of 3 treatment sessions. | — |
Secondary
| Measure | Time frame |
|---|---|
| To identify the post procedural adverse effects of Fractional CO2 Laser and Poly-l-lactic acid (PLLA) Gel versus Fractional CO2 Laser in the treatment of Striae DistensaeTimepoint: at an interval of 4 weeks for a total of 3 treatment sessions. | — |
Countries
India
Contacts
R L Jalappa Hospital